GE HealthCare Technologies Inc. $GEHC Shares Acquired by Profund Advisors LLC

Profund Advisors LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.0% in the second quarter, Holdings Channel reports. The institutional investor owned 39,909 shares of the company’s stock after purchasing an additional 3,954 shares during the period. Profund Advisors LLC’s holdings in GE HealthCare Technologies were worth $2,956,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 3.2% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after acquiring an additional 176,572 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after acquiring an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of GE HealthCare Technologies by 3.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after purchasing an additional 157,839 shares during the period. Canada Pension Plan Investment Board lifted its stake in GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of GE HealthCare Technologies by 3.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after buying an additional 109,858 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $73.05 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a market cap of $33.28 billion, a PE ratio of 15.09, a price-to-earnings-growth ratio of 2.75 and a beta of 1.13. The company’s 50 day simple moving average is $75.12 and its 200-day simple moving average is $73.56.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter last year, the company posted $1.14 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.89%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on GEHC shares. BTIG Research set a $87.00 price target on shares of GE HealthCare Technologies in a research report on Wednesday, October 29th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Morgan Stanley increased their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Barclays began coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target for the company. Finally, Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.